http://www.yourlawyer.com/topics/overview/oxinium_knee_implants Sat, 21 Nov 2009 17:19:29 -0800 pixel-app en http://www.yourlawyer.com/articles/read/7856 Mon, 16 Feb 2004 00:00:00 -0800 http://www.yourlawyer.com/articles/read/7856
"This lawsuit arose from defects related to the knee implants that Smith & Nephew recalled in September 2003 after the 'cementless' versions of its Oxinium Genesis II and Profix II implants in the United States failed to bond properly, resulting a high failure rate," says the lead attorney representing the New Braunfels couple in their claim.

"Patients who received the defective knees may require revision surgery and face added risks of re-infection, further joint and muscular damage and painful rehabilitation," the attorney adds.
]]> http://www.yourlawyer.com/articles/read/7855 Tue, 18 Mar 2003 00:00:00 -0800 http://www.yourlawyer.com/articles/read/7855
The company said yesterday that it had stopped sales of the cementless versions of two of its knee systems because of a higher than expected number of follow-up operations.

According to a Smith & Nephew spokesman, about 30 of the 3,000 patients fitted with cementless versions of its Oxinium Genesis II and Profix II implants in the US have needed to have the procedure revised after the implants became loose. "One per cent is not unusual in this industry but higher than Smith & Nephew would normally see," the spokesman added.

He said the company alerted the US authorities after the problem first came to light last month and had decided to withdraw the products voluntarily for reasons of patient safety while it carried out a valuation to determine what was causing the problem.

Smith & Nephew shares dipped 7p to 400.75p but the company was insistent it did not face the sort of problem that hit Centerpulse some years ago when faulty joints resulted in $1bn of claims. "This is not Centerpulse mark II," the spokesman said. The company had no knowledge of any legal action taken to date.

Knee implants account for about £200m of the group's £1.2bn a year turnover but the products withdrawn from the US market are believed to represent only £2m of sales.

Michael King, analyst at WestLB, said the product withdrawal did not appear to be cause for alarm at this stage. But if the implant needed to be redesigned the delay could cause slower penetration rates of Oxinium into the knee market in the short term.]]> http://www.yourlawyer.com/topics/overview/oxinium_knee_implants Tue, 18 Mar 2003 00:00:00 -0800 http://www.yourlawyer.com/topics/overview/oxinium_knee_implants Oxinium Knee Implants Smith & Nephew Defective Oxinium Cementless Knee Replacements We recommend patients inquire about which knee replacement they will be receiving and do their own due diligence.

Last year, Smith & Nephew voluntarily recalled the cementless versions of its Oxinium Genesis II and Profix II implants. Smith & Nephew recalled these defective knee replacements implants because they did not bond properly. Many patients who received the Oxinium Genesis II and Profix II required revision surgery. Patients that received the Oxinium Genesis II and Profix II are also at higher risk of re-infection, further joint and muscular damage.

Knee replacement surgery is the most popular replacement surgery in the United States. Millions of people have undergone knee replacement surgery since it was introduced in its current form in the 1970s. There are approximately 200,000 to 300,000 knee replacement procedures performed every year in the United States.

People usually undergo knee replacement surgery when the pain has become too severe and no physical therapy or drug treatments are working. While a total knee replacement has a significantly higher success rate than in the past, complications can still arise. The success rate of the replacement operation is greatly influenced by the actual knee replacement that the patient receives.

If you or a loved one suffered injuries from an Oxinium knee implant,  please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney.]]>